"This is a situation where, had Novo Nordisk done the appropriate work upfront ... obtain statistical significance without a very large sample size. Engel is represented by Motley Rice, a firm ...

The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 ...

The outbreak occurred in a flock of 190 backyard poultry birds in the district of Birzgales, Paris-based WOAH said in a notice, citing Latvian authorities. Vera shares skyrocket as kidney disease drug ...

Almost exactly a year after launching its Obesity Association, the American Diabetes Association (ADA) has recruited Novo ...

Novo Nordisk was Europe's most valuable company, with a big lead on obesity drugs with its runaway hits Ozempic and Wegovy.

Novo Nordisk has reached the end of its two-year suspension from the Association of the British Pharmaceutical Industry (ABPI) for breaches of its code of practice, after showing "significant and ...

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent ...

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...

A high-stakes legal battle has erupted ahead of the anticipated launch of Novo Nordisk’s blockbuster weightloss drug Wegovy (semaglutide) in India. The Delhi High Court has restrained Dr Reddy’s ...

New technology and drugs are transforming how doctors detect and treat silent liver disease MASLD before it leads to liver ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

The Biotechnology Market is projected to reach a multimillion-dollar valuation by 2034, driven by an unexpected compound annual growth rate (9.18) from 2025 to 2034.